FDA & Regulatory

Recalls, PMA approvals, and adverse events for heart valve devices

50 events
Adverse EventNov 10, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventNov 10, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic received information that 12 years and 10 months post implant of this 23mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement. The reas...

Adverse EventNov 10, 2026
Adverse Event: AVALUS AORTIC TISSUE VALVE

Medtronic received information that during the implant of this 25mm Avalus heart valve, it was reported that after the valve packaging was opened, a blue, circular, fingertip-sized foreign object was ...

Adverse EventNov 10, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic received information that 5 years and 12 months post implant of this 23mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement. The reaso...

Adverse EventNov 10, 2026
Adverse Event: Mosaic Mitral Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventNov 10, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventNov 10, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventNov 10, 2026
Adverse Event: AVALUS AORTIC TISSUE VALVE

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 30, 2026
Adverse Event: AVALUS AORTIC TISSUE VALVE

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 30, 2026
Adverse Event: OPEN PIVOT MECHANICAL HEART VALVE

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 30, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

Medtronic received information that an unknown duration post implant of this 25mm Mosaic aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement. The ...

Adverse EventOct 30, 2026
Adverse Event: Mosaic Mitral Bioprosthetic Heart Valve

It was reported that 9 years and 2 months post implant of this 25mm mitral bioprosthetic valve implanted in the tricuspid position, the patient received a replacement. The reason for intervention was ...

Adverse EventOct 13, 2026
Adverse Event: FREESTYLE

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Freestyle Aortic Root Bioprosthesis

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic received information that 14 years and 8 months post implant of this 23mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement. The reaso...

Adverse EventOct 13, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Hancock II Aortic Bioprosthetic Heart Valve

Medtronic received information that an unknown duration post implant of this 23mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement. The reason ...

Adverse EventOct 13, 2026
Adverse Event: Freestyle Aortic Root Bioprosthesis

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Mosaic Aortic Bioprosthetic Heart Valve

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventOct 13, 2026
Adverse Event: Freestyle Aortic Root Bioprosthesis

Medtronic submits this report to comply with FDA regulations 21 CFR Parts 4 and 803. Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of ...

Adverse EventSep 9, 2026
Adverse Event: AORTIC FLEX
Adverse EventSep 9, 2026
Adverse Event: MOSAIC
Adverse EventSep 9, 2026
Adverse Event: FREESTYLE
Adverse EventAug 11, 2026
Adverse Event: MOSAIC
Adverse EventAug 11, 2026
Adverse Event: AORTIC VALVE GRAFT
Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC AORTIC BIOPROSTHETIC HEART VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: AVALUS AORTIC TISSUE VALVE

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...

Adverse EventJul 14, 2026
Adverse Event: MOSAIC

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF ...